Ruminococcus (genus)

Ruminococcus is a polyphyletic genus of Gram-positive, strictly anaerobic, non-motile cocci within the phylum Firmicutes (class Clostridia)[1][2][3]. Members are best known for degrading plant cell wall polysaccharides such as cellulose and resistant starches. The genus is strictly associated with host intestinal tracts (mainly herbivores and omnivores, including humans) and is rarely found in the environment outside hosts[1]. Recent phylogenetic research has shown that the name "Ruminococcus" is problematic: what was classically grouped as one genus actually belongs to multiple distinct bacterial families (Ruminococcaceae and Lachnospiraceae), and several species formerly called Ruminococcus have been reclassified into other genera such as Blautia and Mediterraneibacter[1][2]. For example, Ruminococcus gnavus is now considered part of Mediterraneibacter, and not technically a Ruminococcus species[2]. Different Ruminococcus species have distinct metabolic roles, such as: - R. flavefaciens and R. albus: Cellulose degradation (important in ruminants for digestion of plant material)[1]. - R. bromii: Specializes in starch degradation, notably in the human gut microbiome[1]. - R. champanellensis: Unique among human isolates for crystalline cellulose degradation[1]. Because Ruminococcus is a taxonomic group rather than a molecular entity (like a receptor, enzyme, or protein), it is not considered a direct drug target in classical pharmacology. However, its relative abundance or metabolic activity in the gut can influence and reflect host health, and is thus widely studied in microbiome research and may inform future therapeutic or diagnostic approaches[1][2]. Summary: - "Ruminococcus" is not a single therapeutic target but a genus of bacteria, with uncertain clinical targeting value due to taxonomy issues. - It is not drugged as a receptor, enzyme, transporter, or specific molecular target, and it is sometimes used in microbiome analysis but not as a validated pharmacological target. - The taxonomic instability and inconsistent use in the literature make it an **incorrect target name** for drug or biomarker development; if you are interested in a particular species (such as Ruminococcus bromii or Ruminococcus gnavus), those should be specified individually, and their current classification confirmed. If you need data on a **particular species** (e.g., "Ruminococcus bromii" or "Ruminococcus albus"), please specify, as research and classification differ greatly for each. Note: - The genus is under active reclassification; many species previously included under "Ruminococcus" are now assigned to other genera, complicating literature searches and biological interpretation[1][2]. - No standard abbreviation or accepted molecular target code for "Ruminococcus" as a genus; it is not used in drug targeting databases as a molecular target.

Other names

Ruminococci“true ruminococci” (sometimes species have been reclassified into other genera such as Blautia or Mediterraneibacter)